{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:27:38Z","timestamp":1792182458168,"version":"4.4.0"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ijbiomac.2025.145569","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T02:24:26Z","timestamp":1750904666000},"page":"145569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"P3","title":["Investigating the potential of quercetin-loaded chitosan-coated lipid carriers as an oral nanoplatform for depression management"],"prefix":"10.1016","volume":"319","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7529-3459","authenticated-orcid":false,"given":"Moataz B.","family":"Zewail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousra A.","family":"Nomier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"E.Elesawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa A.","family":"El-Dakroury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.145569_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120670","article-title":"Enhanced neuroprotective and antidepressant activity of curcumin-loaded nanostructured lipid carriers in lipopolysaccharide-induced depression and anxiety rat model","volume":"603","author":"Rubab","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0010","first-page":"415","article-title":"Scaling-up treatment of depression and anxiety: a global return on investment analysis, the lancet","volume":"3","author":"Chisholm","year":"2016","journal-title":"Psychiatry"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2013.10.011","article-title":"Development and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression","volume":"48","author":"Haque","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/archpsyc.62.6.629","article-title":"Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication","volume":"62","author":"Wang","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0025","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)02141-3","article-title":"Time for united action on depression: a Lancet\u2013World Psychiatric Association Commission","volume":"399","author":"Herrman","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154566","article-title":"Advances in the mechanisms of polysaccharides in alleviating depression and its complications","volume":"109","author":"Guo","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7015-9-90","article-title":"Cross-national epidemiology of DSM-IV major depressive episode","volume":"9","author":"Bromet","year":"2011","journal-title":"BMC Med."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.focha.2024.100725","article-title":"Enhancing the bioavailability and gut health benefits of quercetin from sprouted onions: a comprehensive review in the context of food-derived bioactives","volume":"4","author":"Majid","year":"2024","journal-title":"Food Chem. Adv."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0045","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/ph16071020","article-title":"Recent advances in potential health benefits of quercetin","volume":"16","author":"Aghababaei","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0050","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/FBP.0000000000000480","article-title":"Quercetin mitigates anxiety-like behavior and normalizes hypothalamus\u2013pituitary\u2013adrenal axis function in a mouse model of mild traumatic brain injury","volume":"30","author":"Kosari-Nasab","year":"2019","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0055","doi-asserted-by":"crossref","first-page":"561","DOI":"10.5958\/0974-360X.2019.00100.8","article-title":"The neuro-protective effects of quercetin","volume":"12","author":"Samini","year":"2019","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104955","article-title":"Neuropharmacological interventions of quercetin and its derivatives in neurological and psychological disorders","volume":"144","author":"Agrawal","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0065","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neuroscience.2013.09.044","article-title":"Quercetin suppress microglial neuroinflammatory response and induce antidepressent-like effect in olfactory bulbectomized rats","volume":"255","author":"Rinwa","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0070","series-title":"Pharmacological, Psychological, and Non-invasive Brain Stimulation Interventions for Treating Depression after Stroke","author":"Allida","year":"2020"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2023.102313","article-title":"Quercetin mitigates depression-like behavior via the suppression of neuroinflammation and oxidative damage in corticosterone-induced mice","volume":"132","author":"Ge","year":"2023","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.598617","article-title":"Quercetin-conjugated superparamagnetic iron oxide nanoparticles protect AlCl3-induced neurotoxicity in a rat model of Alzheimer\u2019s disease via antioxidant genes, APP gene, and miRNA-101","volume":"14","author":"Amanzadeh Jajin","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0085","series-title":"Promises of a biocompatible nanocarrier in improved brain delivery of quercetin: biochemical, pharmacokinetic and biodistribution evidences","author":"Pramod Kumar","year":"2016"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0090","doi-asserted-by":"crossref","first-page":"20683","DOI":"10.1021\/acsomega.2c00912","article-title":"Development of Lepidium sativum extracts\/PVA electrospun nanofibers as wound healing dressing","volume":"7","author":"Amer","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108622","article-title":"Quercetin loaded nanoemulsion-based gel for rheumatoid arthritis: in vivo and in vitro studies","volume":"112","author":"Gokhale","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0100","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41598-023-27665-6","article-title":"Exploring the potential of intranasally administered naturally occurring quercetin loaded into polymeric nanocapsules as a novel platform for the treatment of anxiety","volume":"13","author":"Mahmoud","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2023.102307","article-title":"Neuroprotective effect of quercetin nanoparticles: a possible prophylactic effect in cerebellar neurodegenerative disorders","volume":"132","author":"El-Tahawy","year":"2023","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.580118","article-title":"Lipid nanoparticles as carriers for bioactive delivery","volume":"9","author":"Dhiman","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0115","series-title":"Lipid-Based Nanocarriers: An Attractive Approach for Rheumatoid Arthritis Management","author":"Zewail","year":"2024"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122006","article-title":"Design, characterization and in vivo performance of solid lipid nanoparticles (SLNs)-loaded mucoadhesive buccal tablets for efficient delivery of Lornoxicam in experimental inflammation","volume":"624","author":"Zewail","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0125","article-title":"Preparation and in vitro characterization of a novel self-nano emulsifying drug delivery system for a fixed-dose combination of candesartan cilexetil and hydrochlorothiazide","volume":"61","author":"Zewail","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0130","article-title":"Chitosan coated clove oil-based nanoemulsion: an attractive option for oral delivery of leflunomide in rheumatoid arthritis","volume":"123224","author":"Zewail","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0135","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.lfs.2018.03.010","article-title":"Therapeutic evaluation of solid lipid nanoparticle of quercetin in pentylenetetrazole induced cognitive impairment of zebrafish","volume":"199","author":"Rishitha","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0140","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.2042-7158.2010.01225.x","article-title":"Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery","volume":"63","author":"Dhawan","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0145","article-title":"Preparation and characterization of nanostructured lipid carrier (NLC) and nanoemulsion containing vitamin D3","volume":"1\u201316","author":"Jafarifar","year":"2022","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0150","first-page":"115","article-title":"Development and evaluation of lipid nanocarriers for quercetin delivery: a comparative study of solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), and lipid nanoemulsions (LNE), LWT-food","volume":"59","author":"Aditya","year":"2014","journal-title":"Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0155","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2017.08.033","article-title":"Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases","volume":"264","author":"Tapeinos","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3390\/ph15030281","article-title":"Lipid nanocarriers overlaid with chitosan for brain delivery of berberine via the nasal route","volume":"15","author":"Abo El-Enin","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0165","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijpharm.2014.05.004","article-title":"Pharmacoscintigraphic evaluation of potential of lipid nanocarriers for nose-to-brain delivery of antidepressant drug","volume":"470","author":"Alam","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0170","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3390\/pharmaceutics12111059","article-title":"Boosting the brain delivery of Atazanavir through nanostructured lipid carrier-based approach for mitigating neuroaids","volume":"12","author":"Khan","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119990","article-title":"Berberine loaded nanostructured lipid carrier for Alzheimer\u2019s disease: design, statistical optimization and enhanced in vivo performance","volume":"285","author":"Raju","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0180","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1021\/acschemneuro.8b00510","article-title":"Brain delivery of curcumin using solid lipid nanoparticles and nanostructured lipid carriers: preparation, optimization, and pharmacokinetic evaluation","volume":"10","author":"Sadegh Malvajerd","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0185","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1080\/10717544.2016.1189465","article-title":"Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?","volume":"23","author":"Qu","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0190","article-title":"Fabrication and evaluation of chitosan-coated nanostructured lipid carriers for co-delivery of paclitaxel and PD-L1 siRNA","volume":"124835","author":"Kim","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0195","article-title":"Chitosan coated lipid carriers as nanoplatform for repurposed anti-breast cancer activity of niclosamide","volume":"93","author":"Elkholy","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118447","article-title":"Coated nanostructured lipid carriers targeting the joints \u2013 an effective and safe approach for the oral management of rheumatoid arthritis","volume":"567","author":"Zewail","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0205","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fbioe.2020.00389","article-title":"Potential of chitosan and its derivatives for biomedical applications in the central nervous system","volume":"8","author":"Ojeda-Hern\u00e1ndez","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0210","article-title":"Development of famotidine-loaded lecithin-chitosan nanoparticles for prolonged and efficient anti-gastric ulcer activity","volume":"91","author":"Zewail","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0215","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ijbiomac.2021.08.035","article-title":"Hybrid lipid core chitosan-TPGS shell nanocomposites as a promising integrated nanoplatform for enhanced oral delivery of sulpiride in depressive disorder therapy","volume":"188","author":"Mohyeldin","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0220","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1080\/21691401.2018.1477788","article-title":"Mucoadhesive chitosan-coated PLGA nanoparticles for oral delivery of ferulic acid","volume":"46","author":"de Lima","year":"2018","journal-title":"Artif. Cells, Nanomedicine, Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0225","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s10068-015-0224-7","article-title":"Effects of a chitosan coating on properties of retinol-encapsulated zein nanoparticles","volume":"24","author":"Park","year":"2015","journal-title":"Food Sci. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0230","article-title":"Chitosan-decorated nanoparticles for drug delivery","volume":"59","author":"Del Prado-Audelo","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0235","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jconrel.2015.12.047","article-title":"Oral nanomedicine approaches for the treatment of psychiatric illnesses","volume":"223","author":"Dening","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0240","article-title":"PEGylated lipid polymeric nanoparticles for management of rheumatoid arthritis","volume":"101","author":"Zewail","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0245","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3390\/pharmaceutics13040437","article-title":"Evaluation and comparison of solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) as vectors to develop hydrochlorothiazide effective and safe pediatric oral liquid formulations","volume":"13","author":"Mura","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0250","article-title":"Fexofenadine-loaded chitosan coated solid lipid nanoparticles (SLNs): a potential oral therapy for ulcerative colitis","volume":"114205","author":"El-Dakroury","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0255","article-title":"Design, optimization, and in-vivo performance of glipizide-loaded O-carboxymethyl chitosan nanoparticles in insulin resistant\/type 2 diabetic rat model","volume":"79","author":"El-Dakroury","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121303","article-title":"Famotidine-loaded solid self-nanoemulsifying drug delivery system demonstrates exceptional efficiency in amelioration of peptic ulcer","volume":"611","author":"El-Dakroury","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0265","doi-asserted-by":"crossref","first-page":"97613","DOI":"10.1039\/C6RA17141A","article-title":"Quercetin-loaded solid lipid nanoparticles improve osteoprotective activity in an ovariectomized rat model: a preventive strategy for post-menopausal osteoporosis","volume":"6","author":"Ahmad","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028330","article-title":"Dose-dependent effects of endotoxin on neurobehavioral functions in humans","volume":"6","author":"Grigoleit","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0275","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.physbeh.2017.01.006","article-title":"Quercetin prevents chronic unpredictable stress induced behavioral dysfunction in mice by alleviating hippocampal oxidative and inflammatory stress","volume":"171","author":"Mehta","year":"2017","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113245","article-title":"Quercetin alleviates chronic unpredictable mild stress-induced depressive-like behaviors by promoting adult hippocampal neurogenesis via FoxG1\/CREB\/BDNF signaling pathway","volume":"406","author":"Ma","year":"2021","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0285","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0031-9384(99)00051-7","article-title":"Effect of predatory stress on sucrose intake and behavior on the plus-maze in male mice","volume":"67","author":"Calvo\u2013Torrent","year":"1999","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0290","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0166-4328(01)00452-1","article-title":"Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice","volume":"134","author":"Carola","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0295","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/sj.npp.1300413","article-title":"Genetic and pharmacological evidence of a role for GABAB receptors in the modulation of anxiety-and antidepressant-like behavior","volume":"29","author":"Mombereau","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0300","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1523\/JNEUROSCI.5634-11.2012","article-title":"HDAC6 regulates glucocorticoid receptor signaling in serotonin pathways with critical impact on stress resilience","volume":"32","author":"Espallergues","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0305","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","article-title":"Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles","volume":"31","author":"He","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0310","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/2277-9175.100147","article-title":"Optimization of LDL targeted nanostructured lipid carriers of 5-FU by a full factorial design","volume":"1","author":"Andalib","year":"2012","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0315","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jsps.2012.11.005","article-title":"Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia","volume":"21","author":"Uprit","year":"2013","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0320","doi-asserted-by":"crossref","first-page":"198","DOI":"10.14499\/indonesianjpharm28iss4pp198","article-title":"Effect of lipid ratio of stearic acid and oleic acid on characteristics of nanostructure lipid carrier (NLC) system of diethylammonium diclofenac","volume":"28","author":"Hendradi","year":"2017","journal-title":"Indones. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0325","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.xphs.2021.04.012","article-title":"The effects of solid and liquid lipids on the physicochemical properties of nanostructured lipid carriers","volume":"110","author":"Apostolou","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0330","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.foodhyd.2008.09.017","article-title":"Stability of emulsions for parenteral feeding: preparation and characterization of o\/w nanoemulsions with natural oils and Pluronic f68 as surfactant","volume":"23","author":"Wulff-P\u00e9rez","year":"2009","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0335","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.biopha.2018.04.055","article-title":"Nanostructured lipid carriers for site-specific drug delivery","volume":"103","author":"Khosa","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0340","doi-asserted-by":"crossref","first-page":"143","DOI":"10.15171\/apb.2016.021","article-title":"The impact of variables on particle size of solid lipid nanoparticles and nanostructured lipid carriers; a comparative literature review","volume":"6","author":"Bahari","year":"2016","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0345","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/10717540903431586","article-title":"Preparation and characterization of silybin-loaded nanostructured lipid carriers","volume":"17","author":"Jia","year":"2010","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0350","article-title":"Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications","volume":"1841\u20131850","author":"Gokce","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0355","first-page":"1912","article-title":"Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using box-Behnken design","volume":"23","author":"Kaur","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111331","article-title":"Chitosan-coated nanostructured lipid carriers of fenofibrate with enhanced oral bioavailability and efficacy","volume":"196","author":"Pyo","year":"2020","journal-title":"Colloids Surfaces B Biointerfaces."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0365","series-title":"Silica\/Quercetin Sol\u2013Gel Hybrids as Antioxidant Dental Implant Materials","author":"Catauro","year":"2015"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0370","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/foods9020123","article-title":"Improving stability and accessibility of quercetin in olive oil-in-soy protein isolate\/pectin stabilized O\/W emulsion","volume":"9","author":"Wang","year":"2020","journal-title":"Foods"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0375","doi-asserted-by":"crossref","first-page":"21463","DOI":"10.1038\/s41598-021-99743-6","article-title":"A pre-formulation study of tetracaine loaded in optimized nanostructured lipid carriers","volume":"11","author":"Castro","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0380","doi-asserted-by":"crossref","first-page":"95010","DOI":"10.1088\/2053-1591\/2\/9\/095010","article-title":"Synthesis and characterization of magnetite\/PLGA\/chitosan nanoparticles","volume":"2","author":"Ibarra","year":"2015","journal-title":"Mater. Res. Express."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114324","article-title":"Desosomes and desimicelles\u2212 a novel vesicular and micellar system for enhanced oral delivery of poorly soluble drug: optimization of in vitro characteristics and in vivo performance","volume":"200","author":"Said","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0390","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1080\/13880209.2022.2136208","article-title":"Ameliorative effect of chitosan nanoparticles against carbon tetrachloride-induced nephrotoxicity in Wistar rats","volume":"60","author":"Nomier","year":"2022","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0395","first-page":"31","article-title":"Drug-phospholipid complex-loaded matrix film formulation for the enhanced transdermal delivery of quercetin","volume":"9","author":"Telange","year":"2018","journal-title":"J. Excipients Food Chem."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0400","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1166\/jbn.2013.1636","article-title":"Lipid colloidal carriers for improvement of anticancer activity of orally delivered quercetin: formulation, characterization and establishing in vitro\u2013in vivo advantage","volume":"9","author":"Jain","year":"2013","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0405","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s13204-019-01178-z","article-title":"Novel synthesis of high-thermal stability carbon dots and nanocomposites from oleic acid as an organic substrate","volume":"10","author":"Rimal","year":"2020","journal-title":"Appl. Nanosci."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0410","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1007\/s00289-022-04436-3","article-title":"Preparation of melatonin novel-mucoadhesive nanoemulsion used in the treatment of depression","volume":"80","author":"Ahmad","year":"2023","journal-title":"Polym. Bull."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2020.105037","article-title":"Nanostructured lipid carriers as a strategy for encapsulation of active plant constituents: formulation and in vitro physicochemical characterizations","volume":"235","author":"Chaudhari","year":"2021","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.22146\/ifnp.70925","article-title":"Formulation and characteristics of red palm oil Nanostractured lipid carriers prepared by microemulsion method and its application in drinking yoghurt","volume":"19","author":"Elianarni","year":"2022","journal-title":"Indones. Food Nutr. Prog."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0425","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijpharm.2007.06.036","article-title":"Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles","volume":"346","author":"Wu","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0430","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0731-7085(03)00529-6","article-title":"Study of freeze-dried quercetin\u2013cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis","volume":"34","author":"Pralhad","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13111912","article-title":"Annatto oil loaded nanostructured lipid carriers: a potential new treatment for cutaneous Leishmaniasis","volume":"13","author":"Ferreira","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0440","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ijbiomac.2019.03.019","article-title":"Synthesis, characterization and application of copper oxide chitosan nanocomposite for green regioselective synthesis of [1,2,3] triazoles","volume":"130","author":"Khalil","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126856","article-title":"Cobalt oxide-chitosan based nanocomposites: synthesis, characterization and their potential pharmaceutical applications","volume":"253","author":"Bashal","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0450","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.2147\/IJN.S215835","article-title":"Formulation and evaluation of nanostructured lipid carriers (NLCs) of 20(S)-Protopanaxadiol (PPD) by box-Behnken design","volume":"14","author":"Kim","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121712","article-title":"Pectin coated nanostructured lipid carriers for targeted piperine delivery to hepatocellular carcinoma","volume":"619","author":"Shehata","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0460","first-page":"400","article-title":"Chitosan-coated nanostructured lipid carriers for effective brain delivery of Tanshinone IIA in Parkinson\u2019s disease: interplay between nuclear factor-kappa \u03b2 and cathepsin B, drug Deliv","volume":"14","author":"Hassan","year":"2024","journal-title":"Transl. Res."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0465","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3109\/10717544.2015.1048491","article-title":"Etoposide-loaded nanostructured lipid carriers for gastric cancer therapy","volume":"23","author":"Jiang","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0470","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.3390\/pharmaceutics14112527","article-title":"Quercetin loaded cationic solid lipid nanoparticles in a Mucoadhesive in situ gel\u2014a novel Intravesical therapy tackling bladder Cancer","volume":"14","author":"Shawky","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264825","article-title":"Comparative statistical analysis of the release kinetics models for nanoprecipitated drug delivery systems based on poly (lactic-co-glycolic acid)","volume":"17","author":"Heredia","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0480","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijpharm.2016.11.007","article-title":"Development of near zero-order release PLGA-based microspheres of a novel antipsychotic","volume":"516","author":"Zhao","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0485","first-page":"388","article-title":"Mathematical models of drug dissolution: a review","volume":"3","author":"Ramteke","year":"2014","journal-title":"Sch. Acad. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0490","first-page":"12","article-title":"Release kinetics\u2013concepts and applications","volume":"8","author":"Paarakh","year":"2018","journal-title":"Int. J. Pharm. Res. Technol."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0495","first-page":"52","article-title":"Study the using of nanoparticles as drug delivery system based on mathematical models for controlled release","volume":"8","author":"Ahmed","year":"2019","journal-title":"IJLTEMAS"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0500","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.physa.2017.05.033","article-title":"Interpreting the Weibull fitting parameters for diffusion-controlled release data","volume":"486","author":"Ignacio","year":"2017","journal-title":"Phys. A Stat. Mech. Its Appl."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0505","article-title":"A comparison of models for the analysis of the kinetics of drug release from PLGA-based nanoparticles","volume":"6","author":"Jahromi","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0510","first-page":"125","article-title":"Mathematical modeling of drug release from swellable polymeric nanoparticles","volume":"7","author":"Azadi","year":"2017","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0515","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s11095-021-03126-5","article-title":"Olmesartan niosomes ameliorates the indomethacin-induced gastric ulcer in rats: insights on MAPK and Nrf2\/HO-1 signaling pathway","volume":"38","author":"Sallam","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0520","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijpharm.2016.03.048","article-title":"Setting accelerated dissolution test for PLGA microspheres containing peptide, investigation of critical parameters affecting drug release rate and mechanism","volume":"505","author":"Tomic","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0525","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/10837450.2018.1515225","article-title":"Mucoadhesive chitosan-coated nanostructured lipid carriers for oral delivery of amphotericin B","volume":"24","author":"Ling Tan","year":"2019","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0530","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12951-023-02150-4","article-title":"Enhanced antidepressant effects of BDNF-quercetin alginate nanogels for depression therapy","volume":"21","author":"Xu","year":"2023","journal-title":"J. Nanobiotechnology."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0535","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0540","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0545","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0550","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1098\/rstb.2010.0217","article-title":"Coping styles and behavioural flexibility: towards underlying mechanisms","volume":"365","author":"Coppens","year":"2010","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0555","first-page":"52587","article-title":"The forced swim test as a model of depressive-like behavior","author":"Yankelevitch-Yahav","year":"2015","journal-title":"J. Vis. Exp. JoVE."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0560","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.euroneuro.2023.08.496","article-title":"Sucrose preference test: a systematic review of protocols for the assessment of anhedonia in rodents","volume":"77","author":"Primo","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0565","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/s41596-018-0011-z","article-title":"Sucrose preference test for measurement of stress-induced anhedonia in mice","volume":"13","author":"Liu","year":"2018","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0570","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3390\/ijms23031616","article-title":"C-reactive protein as a biomarker for major depressive disorder?","volume":"23","author":"Orsolini","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0575","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/2013.jamapsychiatry.102","article-title":"Elevated C-reactive protein levels, psychological distress, and depression in 73 131 individuals","volume":"70","author":"Wium-Andersen","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0580","unstructured":"A.A. Jensen, P.A. Davies, H. Br\u00e4uner-Osborne, K. Krzywkowski, M.A. Geyer, F.X. Vollenweider, M.J. Millan, P. Marin, J. Bockaert, C.M. la Cour, 433 Serotonin and Depression: Pathophysiological Mechanism or Marketing Myth?, (n.d.)."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0585","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1523\/JNEUROSCI.4982-07.2008","article-title":"Low-serotonin levels increase delayed reward discounting in humans","volume":"28","author":"Schweighofer","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0590","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/1028415X.2019.1587247","article-title":"Anti-depressant like effects of quercetin 4\u2019-O-glucoside from Allium cepa via regulation of brain oxidative stress and monoamine levels in mice subjected to unpredictable chronic mild stress","volume":"24","author":"Singh","year":"2021","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0595","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/cns.12189","article-title":"Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington\u2019s disease","volume":"20","author":"Chakraborty","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0600","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/pr.111.005108","article-title":"Brain-derived neurotrophic factor and neuropsychiatric disorders","volume":"64","author":"Autry","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0605","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.drudis.2013.07.010","article-title":"Neurotrophin delivery using nanotechnology","volume":"18","author":"Angelova","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0610","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/pharmaceutics5010127","article-title":"From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF)","volume":"5","author":"G\u00e9ral","year":"2013","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0615","first-page":"599","article-title":"Effects of quercetin on spatial memory, hippocampal antioxidant defense and BDNF concentration in a rat model of Parkinson\u2019s disease: an electrophysiological study","volume":"11","author":"Naghizadeh","year":"2021","journal-title":"Avicenna J. Phytomedicine."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0620","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3389\/fphar.2019.01544","article-title":"Quercetin alleviates LPS-induced depression-like behavior in rats via regulating BDNF-related imbalance of copine 6 and TREM1\/2 in the hippocampus and PFC","volume":"10","author":"Fang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0625","doi-asserted-by":"crossref","first-page":"8982","DOI":"10.1074\/jbc.275.12.8982","article-title":"Down-regulation of the neurotrophin receptor TrkB following ligand binding: evidence for an involvement of the proteasome and differential regulation of TrkA and TrkB","volume":"275","author":"Sommerfeld","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114503","article-title":"Quercetin abrogates lipopolysaccharide-induced depressive-like symptoms by inhibiting neuroinflammation via microglial NLRP3\/NF\u03baB\/iNOS signaling pathway","volume":"450","author":"Adeoluwa","year":"2023","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0635","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijpharm.2010.08.020","article-title":"Tight junction modulation by chitosan nanoparticles: comparison with chitosan solution","volume":"400","author":"Vllasaliu","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0640","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1016\/j.biomaterials.2011.03.056","article-title":"Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening","volume":"32","author":"Yeh","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0645","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1021\/acs.molpharmaceut.4c00392","article-title":"On the structure, stability, and cell uptake of nanostructured lipid carriers for drug delivery","volume":"21","author":"Jeitler","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.145569_bb0650","article-title":"Cell Membrane\u2010Coated Lipid Nanoparticles for Drug Delivery","author":"Zewail","year":"2025","journal-title":"Aggregate"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025061240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025061240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T02:08:54Z","timestamp":1770775734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025061240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":130,"alternative-id":["S0141813025061240"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145569","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating the potential of quercetin-loaded chitosan-coated lipid carriers as an oral nanoplatform for depression management","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145569","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"145569"}}